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WAGR SYNDROME - A CASE REPORT 
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SUMMARY - Congenital anomaly syndrome consisting of Wilms tumor, aniridia, genitourinary 
malformations and mental retardation (WAGR) is a rare, sporadic genetic disorder characterized 
by a de novo deletion in the distal band of llp13 chromosome. The syndrome is usually recognized 
by sporadic aniridia present at birth, often followed by the development of Wilms tumor in early 
childhood, but possible at any age. Genetic testing using fluorescence in situ hybridization (FISH) 
is the method of choice to detect specific deletions. The multidisciplinary approach in medical tre-
atment not only of the tumor, but of a large variety of clinical features and possible complications 
is highly demanding and challenging. We report on a boy born with aniridia, cryptorchidism and 
facial dysmorphism recognized as WAGR syndrome in neonatal period, subsequently confirmed by 
genetic testing. Wilms tumor developed at the age of one year. Surgical treatment and chemotherapy 
resulted in complete remission for almost six years now. However, an increased risk oflate post-tre-
atment complications and development of de novo tumor in the contralateral kidney is a permanent 
threat. Therefore, ongoing oncologic follow up along with ophthalmologic and neurologic treatment 
and psychological support are a lifelong necessity. 
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Introduction 
WAG R syndrome is a congenital anomaly syn-
drome consisting of Wilms tumor, aniridia, genitouri-
nary anomalies and mental retardation, first described 
in 1964 by Miller et aU. It is a rare, sporadic genetic 
disorder characterized by a de novo deletion in the 
distal band of 11p13 chromosome2) The deletion of 
several neighboring genes including the PAX6 ocular 
development gene and Wilms tumor gene (WT1) re-
sults in both aniridia and an increased risk of Wilms 
tumor4. Abnormalities in the Wilms tumor gene are 
also thought to be responsible for genital anomalies 
and nephropathies often seen in this disorder. Defi-
ciencies in the PAX6 gene may also result in abnor-
malities of the brain and pancreas5. 
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WAGR syndrome usually manifests in the neo-
natal period with bilateral sporadic aniridia. Geni-
tourinary anomalies may be absent, particularly in 
girls; concurrent development of these anomalies and 
aniridia should raise suspicion of WAGR syndrome. 
Craniofacial dysmorphism presents with a long, nar-
row face, prominent nose, low-set ears with poor lobu-
lation, down-slanted palpebral aperture, stubby nose, 
long poorly demarcated philtrum, and thin upper lip 
with tracheomalacia and delayed closure of anterior 
fontanelle. In addition to classic presentation, there is 
a large variety of phenotypic manifestations and seri-
ous complications for which the disorder is less well 
known. Non-classic clinical findings may include 
ocular (cataracts, glaucoma, nystagmus, optic nerve 
hypoplasia, macular/foveal hypoplasia, retinal detach-
ment, strabismus), genitourinary (ambiguous genita-
lia, hypospadia, anomalies of the uterus, gonadoblas-
toma, inguinal hernia) and neurologic disturbances 
and anomalies (epilepsy, cerebral palsy, developmen-
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tal anomalies of the brain)'- Defects in the endocrine 
pancreas can lead to the development of non-insulin 
dependent diabetes or chronic pancreatitis? Obesity 
and hyperphagia are common, but not specifically de-
scribed as a feature of the syndrome. Recent studies 
found connection between brain derived neurotrophic 
factor (BDNF) insufficiency and childhood-onset 
obesity in WACR(O) syndrome8 
Case Report 
A boy was born to a healthy 38-year-old mother 
after uneventful, first pregnancy, birth weight 3380 g 
and birth length 49 cm. Aniridia, facial dysmorphism 
and cryptorchidism were noticed on the first physi-
cal examination immediately after birth. The neonate 
showed mild hypotonia, while primitive reflexes were 
normal. Ophthalmologic examination on the sec-
ond day of life confirmed aniridia, congenital glau-
coma and polar cataract on both eyes. According to 
guidelines in such cases, genetic screening for WAGR 
syndrome using lymphocyte high-resolution chromo-
some study failed to detect typical deletions. There-
fore, a wide spectrum of different laboratory tests such 
as serologic tests for congenital TORCH infections, 
screening tests for congenital metabolic diseases and 
ultrasonography of different organs and systems were 
performed. Brain ultrasound showed no developmen-
tal abnormalities, just mild dilatation of the lateral 
ventricles with periventricular echodensity. Because 
of the limited diagnostic possibilities of sonography, 
computed tomography (CT) scan was indicated, how-
ever, revealing no other lesions. Urinary tract ultra-
sonography showed mild dilatation of the right renal 
pelvis and ureter, while dynamic scintigraphy of the 
kidneys confirmed mild elimination disturbances ip-
silaterally. Periodic nephrologic follow up examina-
tions and abdominal sonography were scheduled at 
three-month intervals. 
The diagnosis was finally confirmed at the age of 
five months by additional genetic testing using fluo-
rescence in situ hybridization (FISH). Deletion in the 
distal band of11p13 chromosome was verified. At that 
time, developmental delay was obvious and intensive 
rehabilitation treatment was introduced. 
Progressive glaucoma of the left eye required 
early ophthalmologic surgical intervention at the age 
456 
WAGR syndrome - a case report 
of nine months, followed by continuous conserva-
tive treatment. Over two months of the child's first 
birthday, the parents noticed mild, but progressive 
asymmetric enlargement of the right hemiabdomen. 
Multi-slice CT scan showed massive tumor of the 
right kidney extending inferiorly to the pelvis and to 
the other side of the vertebral line, with compression 
of the aorta and vena cava inferior and metastases 
to the paravertebral lymphatic nodes and the right 
lung. At the age of 14 months, surgical extirpation 
of the tumor and all regional lymph nodes was done, 
along with orchidectomy of the retained right testis 
that was incorporated into the tumor mass. Accord-
ing to anatomic extent, the tumor was classified as 
stage IVb. Pathology findings confirmed the diag-
nosis of Wilms tumor, with predominant blastemic 
components and absence of anaplasia. Surgical treat-
ment was followed by chemotherapy according to 
the Societe Internationale d'Oncologie Pediatrique 
protocol for Wilms tumor (SIOP-WT-2001). Due to 
classification as a high risk tumor, chemotherapy was 
administered for 34 weeks. As control chest radiog-
raphy showed complete remission of pulmonary me-
tastases and abdominal CT scan revealed no other 
metastases, irradiation was not performed. A11 di-
agnostic and therapeutic procedures were associated 
with usual side effects, free from any serious compli-
cations. 
At the age of three years, hormonal tests were 
done to decide on the left testis orchidopexy. Accord-
ing to testosterone level recorded on human chorionic 
gonadotropin (hCC) stimulation test, functional go-
nadal tissue was detected and operative treatment for 
cryptorchidism seemed reasonable. However, only 
rudiment of the left testis was found high in the ret-
roperitoneal space. 
Regular oncologic follow up performed to the 
present, at the age of eight years, showed complete 
remission and no signs of relapse, with normal renal 
function tests. After the glaucoma operation in the 
early childhood, only conservative ophthalmologic 
treatment was needed, with regular follow up. Besides 
developmental delay and mild mental retardation, the 
patient had no other neurologic disturbances. Under 
the care of different specialists such as neurologists, 
psychologists and special teachers, the boy attends 
school with special educational programs. 
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Discussion 
WAG R syndrome is a complex entity consisting 
of clinical features usually present in neonatal period 
with sporadic aniridia. The prevalence of sporadic 
aniridia is estimated to 1 per 100 000 live births. 
Approximately one third of patients with sporadic 
aniridia will have WAGR syndrome, thus thorough 
evaluation for the syndrome is recommended in a11 in-
fants with sporadic aniridia9. Genetic testing consist-
ing of lymphocyte high-resolution chromosome study 
is usually performed, however, very small deletions 
may not be detected. Therefore, FISH is the method 
of choice to analyze mutations in sporadic aniridia10. 
Using this method, the exact extent of deletions can 
be determined and the risk of Wilms tumor calcu-
latedll 
Once the diagnosis has been confirmed, multidis-
ciplinary care is warranted. Ultrasound screening for 
Wilms tumor has to be done first. In patients with 
WAGR syndrome, the risk has been estimated to up 
to 45%. The median age at diagnosis is earlier than 
average age (17-27 months versus 38 months)12 There 
are no official guidelines, but continuous renal ultra-
sound at 3-month intervals from birth until at least 
six years of age is reasonable. Physical examination 
(abdominal palpation, blood pressure controls) and 
laboratory testing for hematuria are recommended at 
the same frequency. After age six, thorough physical 
examination should be performed to assess for ab-
dominal masses every 6 months until age 8 and every 
6 to 12 months thereafter. Although Wilms tumor is 
considered unusual after early childhood, there are re-
ports on late-appearing tumor in some patients with 
WAGR syndrome, even at the age of 2513 However, 
clinicians should maintain a high index of suspicion 
for Wilms tumor in patients with WAG R syndrome 
of any agel'. Although the syndrome is not classically 
associated with nephropathies, increased rates of re-
nal failure are reported. However, periodic evaluation 
of serum creatinine and blood urea nitrogen should 
also be considered, such as urine screening for pro-
teinuria. Proteinuria and/or hypertension may occur 
well before changes in serum laboratory findings and 
require prompt referral to nephrologyls It is extremely 
important to emphasize the role of patient's family as 
partners in the ongoing management of medical care 
of the child. Regular ultrasound screening is impor-
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tant as much as teaching the parents how to perform 
abdominal palpation between official visits. 
Wilms tumor as the most common malignant renal 
tumor in children is one of the successes of pediatric 
oncology with an overall cure rate of over 85%. Dra-
matic improvement in survival is the result of multi-
disciplinary team approach to cancer. Surgery remains 
a crucial part of treatment providing local primary 
tumor control and appropriate staging, while possi-
bly controlling metastatic spread and central vascular 
extension of the disease16. The management continues 
to evolve with two different approaches, i.e. the one 
suggesting preoperative chemotherapy, and the other 
recommending primary surgery before any adjuvant 
therapy. Despite these disparate strategies, the overall 
survival is comparable17. Therefore, a real challenge is 
not this dilemma but stratification of treatment inten-
sity according to the clinical, histologic and molecular 
risk factors18 . The current goal is reducing the morbid-
ity associated with chemotherapy, such as cardiomyo-
pathy, renal failure and an increased risk of secondary 
malignancy19. 
If the patient is post-treated for Wilms tumor, 
annual follow up examinations are recommended, 
including laboratory tests (complete blood count, dif-
ferential white blood count, liver function tests, renal 
function tests, urine analysis), routine physical ex-
amination and blood pressure controls. Some studies 
report a high incidence (up to 50%) of unexplained 
end-stage renal disease occurring approximately 10 
years after the diagnosis. If the child has received 
Ifosfamide (cisplatin), plasma and urine electrolyte 
levels, and blood and urine pH have to be checked. 
If the child has received Adriamycin (doxorubicin), 
echo cardiogram and radionuclide angiography are 
recommended, along with cardiologic examination as 
needed20. 
Neurologic assessment for the possible hypotonia, 
hypertonia or movement disorders, along with neu-
roimaging techniques have to be performed as early 
as the diagnosis is verified. A wide spectrum of neu-
rologic, behavioral or psychiatric disorders requiring 
intensive treatment can be expected in very early in-
fanCj;l1 
Ophthalmologic problems are common. Proper 
treatment is needed not only for aniridia, but also due 
to frequent association with cataracts (50%-85%) and 
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less frequent with glaucoma (6%-75%). Glaucoma in 
aniridia is thought to be due to developmental ab-
normalities in the drainage angle of the eye22 The 
treatment is challenging because about half of cases 
fail to respond to conservative therapy. Surgical treat-
ment appears to be as challenging and includes both 
prophylactic and therapeutic surgery. Cataracts often 
necessitate extraction with or without insertion of an 
intraocular lens implant23 . 
Our patient was born with clinical features of 
WAGR syndrome confirmed by FISH genetic test-
ing. After establishing the diagnosis, periodic follow 
up visits were scheduled, however, Wilms tumor de-
veloped in-between. Surgical treatment followed by 
chemotherapy led to complete remission persisting 
for more than five years. However, an increased risk 
of tumor relapse and/or de novo disease in the con-
tralateral kidney with potential development of renal 
failure required oncologic follow up at least once a 
year during childhood. Ophthalmologic treatment is 
a lifelong necessity because of the permanent threat of 
glaucoma or cataract worsening. 
Continuous multidisciplinary treatment of devel-
opmental disabilities facilitated the patient's integra-
tion in school activities; however, transition to adult-
hood will certainly be a highly challenging process for 
both the patient and his close environment. For now, 
the boy has happy childhood, mostly thanks to enor-
mous efforts, care and love of his parents. 
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Saietak 
SINDROM WAGR- PRIKAZ SLUCAJA 
M. Starteviii M. MataiJa 
Sindrom WAG R je rijedak genetski poremeeaj sporadicne pojavnosti koji se klinicki prezentira Wilmsovim tumorom, 
aniridijom, genitourinarnim anomalijama i mentalnom retardacijom. Obiljeien je de novo delecijom u distal nom kraku 
11. kromosoma u regiji 11 p13, a dokazuje se genetskim ispitivanjem metodom fiuorescentne in situ hibridizacije (FISH). 
Sindrom se najceSee prepoznaje po aniridiji prisutnoj kod rodenja, dok se Wilmsov tumor obicno razvija tijekom ranog 
djetinjstva, no moguee je u bilo kojoj iivotnoj dobi. Multidisciplinski pristup je nuian u lijecenju ne sarno tumora, nego 
i raznolikih kliniCkih obiljeija i moguCih komplikacija sindroma koji cine pose ban terapijski izazov. Prikazujemo slueaj 
djeeaka kod kojeg je sindrom WAG R prepoznat u novorodenackoj dobi na temelju kliniCkih obiljeija (aniridija, facijalna 
dizmorfija, kriptorhizam), a potvrden kasnijim genetiCkim testiranjem. U natoc redovitim kontrolama Wilmsov tumor je 
otkriven vee u uznapredovalom stadiju u dobi od 14 mjeseci. Nakon provedenog kirurskog lijecenja i kemoterapije uslijedila 
je potpuna remisija koja traje gotovo sest godina. Medutim, zbog rizika od kasnih poslijeterapijskih komplikacija te razvoja 
de novo tum ora u preostalom, kontralateralom bubregu redovite onkoloske kontrole su doiivotna nuinost, kao i trajna 
oftalmoloska, neuroloska i psiholoska skrb. 
Kljucne rijeci:AniridiJa - genetika; AniridiJa - novotvorine; Sindrom UMGR - komplikaciJe; Sindrom WAGR - diJagnostika; 
Sindrom WAGR - patologija; Kromosomske aberaciJe; Novotvorine bubrega; DiJete; Prikaz slutaja 
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